Rajavelu Esther
Chief Executive Officer, Chief Financial Officer and Chief Business Officer
CIK: 1903716
All Transactions
| Date | Company | Type | Shares | Price | Value | Actions |
|---|---|---|---|---|---|---|
| Feb 6, 2026 | Spero Therapeutics, Inc. (SPRO) | S | 37,101 | $2.36 | $87,558.36 | View Details Filing |
| Feb 6, 2026 | Spero Therapeutics, Inc. (SPRO) | S | 50,816 | $2.36 | $119,925.76 | View Details Filing |
| Feb 2, 2026 | Spero Therapeutics, Inc. (SPRO) | S | 18,442 | $2.20 | $40,572.40 | View Details Filing |